AILEEN LIONG: Open Payments
NPI 1477152619 · RIO RANCHO, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$222 in 10 payments from 8 companies in 2025. Trend: 2023 $15 · 2024 $13 · 2025 $222
Food & beverage: $222
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $57 |
| Lilly USA, LLC | 2 | $35 |
| Madrigal Pharmaceuticals | 1 | $31 |
| Neurocrine BioSciences, Inc. | 1 | $29 |
| Astellas Pharma US Inc | 1 | $19 |
| Dexcom, Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $14 |
Products named: CAPLYTA, MOUNJARO, REZDIFFRA, INGREZZA, Veozah, Dexcom G6 Transmitter, AUSTEDO XR, Cologuard Collection Kit.
Industry payments across NM — which companies pay providers there.
